BR112012023028A2 - bactérias do ácido láctico para doença celíaca. - Google Patents

bactérias do ácido láctico para doença celíaca.

Info

Publication number
BR112012023028A2
BR112012023028A2 BR112012023028A BR112012023028A BR112012023028A2 BR 112012023028 A2 BR112012023028 A2 BR 112012023028A2 BR 112012023028 A BR112012023028 A BR 112012023028A BR 112012023028 A BR112012023028 A BR 112012023028A BR 112012023028 A2 BR112012023028 A2 BR 112012023028A2
Authority
BR
Brazil
Prior art keywords
celiac disease
lactic acid
acid bacteria
strains
lactobacillus
Prior art date
Application number
BR112012023028A
Other languages
English (en)
Other versions
BR112012023028B1 (pt
Inventor
Montserrat Carreras Augusti
Ramon Vidal Daniel
Bataller Leiva Esther
Andreu Corominas Montserrat
Genoves Martinez Salvador
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of BR112012023028A2 publication Critical patent/BR112012023028A2/pt
Publication of BR112012023028B1 publication Critical patent/BR112012023028B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

bactérias do ácido láctico para doença celíaca. a presente invenção refere-se a cepas de lactobacillus e streptococus as quais têm uma capacidade de degradar peptídeos de gliadina envolvidos em doença celíaca e atividade de degradação peptídica a qual é estável sob baixo ph e na presença de enzimas digestivas de mamífero. estas cepas são adequadas em um produto para uso em prevenção e/ou tratamento de doença celíaca.
BR112012023028-0A 2010-03-12 2010-03-12 meio fermentado por uma cepa de bactéria de ácido láctico, composição e seu uso BR112012023028B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2010/000699 WO2011110884A1 (en) 2010-03-12 2010-03-12 Lactic acid bacteria for coeliac disease

Publications (2)

Publication Number Publication Date
BR112012023028A2 true BR112012023028A2 (pt) 2017-02-07
BR112012023028B1 BR112012023028B1 (pt) 2020-12-08

Family

ID=42983265

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012023028-0A BR112012023028B1 (pt) 2010-03-12 2010-03-12 meio fermentado por uma cepa de bactéria de ácido láctico, composição e seu uso

Country Status (7)

Country Link
US (2) US20130121976A1 (pt)
EP (1) EP2545160B1 (pt)
CN (1) CN103097513B (pt)
BR (1) BR112012023028B1 (pt)
EA (1) EA031179B1 (pt)
ES (1) ES2691301T3 (pt)
WO (1) WO2011110884A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
EP2861242B1 (en) * 2012-06-18 2018-08-08 H.J. Heinz Company Brands LLC Gluten-related disorders
WO2014044281A1 (en) 2012-09-19 2014-03-27 Rigshospitalet Inhibition of a 33-mer gliadin peptide for treatment of diabetes
JP2016508510A (ja) * 2013-02-19 2016-03-22 ダノン，エセ．アー． 肥満障害に対する機能性ペプチド
CN110651824A (zh) 2013-05-10 2020-01-07 H.J.海因茨品牌有限责任公司 益生菌和使用方法
US20170196918A1 (en) * 2014-05-23 2017-07-13 Consejo Superior De Investigaciones Cientificas (Csic) New Strain Of Lactobacillus Casei With Ability To Degrade The Immunotoxic Peptide From Gluten
FI127483B (en) 2014-06-11 2018-07-13 Gut Guide Oy Microbial marker for celiac disease and related product
MA42047A (fr) * 2015-05-07 2018-03-14 Gervais Danone Sa Lactosérum acide à teneur stable en lactose
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
AU2020412216A1 (en) 2019-12-23 2022-08-18 Evonik Operations Gmbh Process to identify consortia of probiotic strains suitable for gluten degradation
CN112056496A (zh) * 2020-09-09 2020-12-11 中国农业大学 一种利用乳酸菌降低面团麸质蛋白含量的方法
CN114657091B (zh) * 2022-03-03 2023-08-11 中国疾病预防控制中心传染病预防控制所 一种弯曲菌增菌培养液及其制备方法、应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ITMI20051910A1 (it) * 2005-10-11 2007-04-12 Anidral Srl Metodo per la preparazione di colture batteriche probiotiche anallergiche e relativo impiego
PL1996696T3 (pl) * 2006-03-17 2017-08-31 Probi Aktiebolag Termostabilne szczepy Lactobacillus
EP2065048A1 (en) * 2007-11-30 2009-06-03 Institut Pasteur Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
FR2937252B1 (fr) * 2008-10-17 2011-05-20 Pf Medicament Association d'un extrait de sureau et d'une souche de l. paracasei.
MY147929A (en) * 2009-03-13 2013-02-15 Chan Yap Kee Camera flash reflector assembly

Also Published As

Publication number Publication date
US10603342B2 (en) 2020-03-31
EA031179B1 (ru) 2018-11-30
EA201290902A1 (ru) 2013-04-30
ES2691301T3 (es) 2018-11-26
BR112012023028B1 (pt) 2020-12-08
US20130121976A1 (en) 2013-05-16
CN103097513B (zh) 2018-01-30
EP2545160B1 (en) 2018-07-18
EP2545160A1 (en) 2013-01-16
CN103097513A (zh) 2013-05-08
WO2011110884A1 (en) 2011-09-15
US20170145379A1 (en) 2017-05-25

Similar Documents

Publication Publication Date Title
BR112012023028A2 (pt) bactérias do ácido láctico para doença celíaca.
EP3479824A3 (en) Peptides and their use
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
IN2014DN03449A (pt)
MX2013011835A (es) Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas.
MY156286A (en) Human il-23 antigen binding proteins
AU2011206532A8 (en) Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
CL2013001134A1 (es) Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
MX339951B (es) Bacillus subtilis aislado de maiz.
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
NZ603901A (en) Vectors and sequences for the treatment of diseases
EA201391823A1 (ru) Высушенные распылением штаммы/клетки лактобактерий и их применение против helicobacter pylori
WO2012149615A3 (en) Polybacterial preparation with health benefits: antioxidant effect, reduction of cholesterol concentration, anti-inflammatory immunomodulating effect and release of bioactive peptides inhibiting angiotensin-converting enzyme
MY177379A (en) Low protein infant formula with increased essential amino acids
MX2011013126A (es) Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos.
BR112013028705A2 (pt) cepas bacterianas probióticas e composição simbiótica contendo as mesmas destinadas a alimentos para lactentes
MY160992A (en) Lactobacillus helveticus having high proteolysis activity
EA201390597A1 (ru) Текстурирующие штаммы молочно-кислых бактерий
WO2010064930A8 (en) Use of lactic acid bacteria to treat or prevent eczema
WO2012006384A3 (en) Rothia species gluten-degrading enzymes and uses thereof
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
PH12014501200A1 (en) Bacteriophage gene 3 protein compositions and use as amyloid binding agents
EA201291229A1 (ru) Синергетическая ферментация lactobacillus rhamnosus и lactobacillus paracasei subsp paracasei
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2713 DE 03-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.